CareLit Fachartikel

Acarbose increases atrial natriuretic peptide levels in subjects with metabolic syndrome: A novel mechanism of cardiovascular protection

N Rudovich, A Ernst, O Pivovarova, A Trabert, A Bergmann, AFH Pfeiffer · Diabetologie und Stoffwechsel · 2009 · Heft 05

Dokument
968945
CareLit-ID
Jahr
2009
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Diabetologie und Stoffwechsel
Autor:innen
N Rudovich, A Ernst, O Pivovarova, A Trabert, A Bergmann, AFH Pfeiffer
Ausgabe
Heft 05 / 2009
Seiten
–
Erschienen: 2009-05-19 00:00:00
ISSN
1861-9002

Zusammenfassung

Background: Acarbose unexpectedly reduced blood pressure and especially new cases of hypertension in the STOP NIDDM study. Atrial natriuretic peptide (ANP) is a cardiac hormone that protects cardiovascular integrity through direct vascular relaxation, antagonism of the renin-angiotensin-aldosterone system, renal salt elimination, anti-proliferative and anti-fibrotic effects. Subjects with metabolic syndrome have decreased levels of MR-proANP53–90 for unknown reasons. Insulin decreased circulating ANP levels in humans in our previous studies. We thus hypothesized that acarbose may modulate ANP levels via regulati…

Schlagworte

Diabetologie und Stoffwechsel